Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

Aptar Digital Health's HeroTracker® Sense has been granted by the U.S Food and Drug Administration 510(k) clearance as a ...
MPR

FDA Clears Add-On Device for MDIs to Assess Med Usage, Inhalation Technique

The HeroTracker Sense add-on device is compatible with several commonly prescribed ashtma and COPD medications.
Le Lézard

Wayflyer Launches Hosted Capital to Help Platforms Unlock New Revenue Streams and Boost Customer Retention

Wayflyer, the leading financing platform for consumer brands, today announced the launch of Hosted Capital, a new solution that enables service providers to commerce brands to seamlessly embed lending ...
Le Lézard

Princeton Biopartners Launches EVEXA®: AI-Driven Platform Transforming Evidence Generation and Medical Strategy

Princeton Biopartners, a leading consultancy in Integrated Evidence Generation Planning and Medical Affairs strategy, today announced the launch of EVEXA®, a groundbreaking platform that ...
The Cardiology Advisor

FDA to Review Inhaled Insulin for Pediatric Diabetes

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.